Protection in the aged heart: Preventing the heart-break of old age?

Cardiovascular Research

Volumn 66, Issue 2, 2005, Pages 233-244

  Juhaszova, Magdalena ^a   Rabuel, Christophe ^a   Zorov, Dmitry B ^a   Lakatta, Edward G ^a   Sollott, Steven J ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Aging; Ischemia reperfusion; Mitochondria; Preconditioning; ROS

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLOOXYGENASE 2; ERYTHROPOIETIN; ESTROGEN; GLYCOGEN SYNTHASE KINASE 3BETA; HEAT SHOCK PROTEIN 70; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; LEPTIN; POTASSIUM; POTASSIUM CHANNEL; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN KINASE C EPSILON; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; S6 KINASE; SOMATOMEDIN; UBIDECARENONE;

ACUTE HEART INFARCTION; AGING; ANGIOCARDIOGRAPHY; CALORIC RESTRICTION; CLINICAL PRACTICE; CONGESTIVE HEART FAILURE; ELECTROCARDIOGRAM; ENZYME ACTIVATION; ENZYME ACTIVITY; EXERCISE; HEART; HEART ARRHYTHMIA; HEART FUNCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MITOCHONDRION; HEART PROTECTION; HEMODYNAMICS; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RODENT; ST SEGMENT DEPRESSION;

AGED; AGING; ANIMALS; CARDIOTONIC AGENTS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOCHONDRIA, HEART; MODELS, ANIMAL; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIUM; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 16344391597     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.12.020     Document Type: Review

References (128)

1. S.K. Powers, J. Quindry, and K. Hamilton Aging, exercise, and cardioprotection Ann. N.Y. Acad. Sci. 1019 2004 462 470
2. Z.Q. Zhao, C.D. Morris, J.M. Budde, N.P. Wang, S. Muraki, and H.Y. Sun Inhibition of myocardial apoptosis reduces infarct size and improves regional contractile dysfunction during reperfusion Cardiovasc. Res. 59 2003 132 142
3. M. Crompton The mitochondrial permeability transition pore and its role in cell death Biochem. J. 341 1999 233 249
4. T.D. Miller, T.F. Christian, M.R. Hopfenspirger, D.O. Hodge, B.J. Gersh, and R.J. Gibbons Infarct size after acute myocardial infarction measured by quantitative tomographic 99 mTc sestamibi imaging predicts subsequent mortality Circulation 92 1995 334 341
5. N. Maulik, T. Yoshida, R.M. Engelman, D. Deaton, J.E. Flack III, and J.A. Rousou Ischemic preconditioning attenuates apoptotic cell death associated with ischemia/reperfusion Mol. Cell. Biochem. 186 1998 139 145
6. M. Juhaszova, D.B. Zorov, S.H. Kim, S. Pepe, Q. Fu, and K.W. Fishbein Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore J. Clin. Invest. 113 2004 1535 1549
7. S.A. Javadov, S. Clarke, M. Das, E.J. Griffiths, K.H. Lim, and A.P. Halestrap Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart J. Physiol. 549 2003 513 524
8. D.J. Hausenloy, D.M. Yellon, S. Mani-Babu, and M.R. Duchen Preconditioning protects by inhibiting the mitochondrial permeability transition Am. J. Physiol., Heart Circ. Physiol. 287 2004 H841 H849
9. C.E. Murry, R.B. Jennings, and K.A. Reimer Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 74 1986 1124 1136
10. D.M. Yellon, and J.M. Downey Preconditioning the myocardium: from cellular physiology to clinical cardiology Physiol. Rev. 83 2003 1113 1151
11. D.M. Yellon, A.M. Alkhulaifi, and W.B. Pugsley Preconditioning the human myocardium Lancet 342 1993 276 277
12. E. Deutsch, M. Berger, W.G. Kussmaul, J.W. Hirshfeld Jr., H.C. Herrmann, and W.K. Laskey Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features Circulation 82 1990 2044 2051
13. K. Hong, K.F. Kusano, H. Morita, Y. Fujimoto, X. Wang, and H. Yamanari Attenuation of conduction delay by ischemic preconditioning reduces ischemia-induced ventricular arrhythmias Acta Med. Okayama 53 1999 233 238
14. R.A. Kloner, T. Shook, K. Przyklenk, V.G. Davis, L. Junio, and R.V. Matthews Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation 91 1995 37 45
15. F. Ottani, M. Galvani, D. Ferrini, F. Sorbello, P. Limonetti, and D. Pantoli Prodromal angina limits infarct size. A role for ischemic preconditioning Circulation 91 1995 291 297
16. R.A. Kloner, and D. Yellon Does ischemic preconditioning occur in patients? J. Am. Coll. Cardiol. 24 1994 1133 1142
17. F. Tomai, M. Perino, A.S. Ghini, F. Crea, A. Gaspardone, and F. Versaci Exercise-induced myocardial ischemia triggers the early phase of preconditioning but not the late phase Am. J. Cardiol. 83 1999 586 588
18. P.D. Lambiase, R.J. Edwards, M.R. Cusack, C.A. Bucknall, S.R. Redwood, and M.S. Marber Exercise-induced ischemia initiates the second window of protection in humans independent of collateral recruitment J. Am. Coll. Cardiol. 41 2003 1174 1182
19. K.W. Mahaffey, J.A. Puma, N.A. Barbagelata, M.F. DiCarli, M.A. Leesar, and K.F. Browne Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction Study of Adenosine (AMISTAD) trial J. Am. Coll. Cardiol. 34 1999 1711 1720
20. R. Diaz, E.A. Paolasso, L.S. Piegas, C.D. Tajer, M.G. Moreno, and R. Corvalan Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) collaborative group Circulation 98 1998 2227 2234
21. I.C. van der Horst, F. Zijlstra, A.W. van't Hof, C.J. Doggen, M.J. de Boer, and H. Suryapranata Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial J. Am. Coll. Cardiol. 42 2003 784 791
22. H.J. Rupprecht, J. vom Dahl, W. Terres, K.M. Seyfarth, G. Richardt, and H.P. Schultheibeta Cardioprotective effects of the Na(+)/H(+) exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA Circulation 101 2000 2902 2908
23. U. Zeymer, H. Suryapranata, J.P. Monassier, G. Opolski, J. Davies, G. Rasmanis ESCAMI Investigators The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial J. Am. Coll. Cardiol. 38 2001 1644 1650
24. R.M. Mentzer Jr. The EXPEDITION Study Investigators Effects of Na+/H+ exchange inhibition by cariporide on death and nonfatal myocardial infarction in patients undergoing coronary artery bypass graft surgery: the EXPEDITION Study Circulation 108 2003 3M
25. K. Ytrehus, Y. Liu, and J.M. Downey Preconditioning protects ischemic rabbit heart by protein kinase C activation Am. J. Physiol. 266 1994 H1145 H1152
26. M.E. Speechly-Dick, M.M. Mocanu, and D.M. Yellon Protein kinase C. Its role in ischemic preconditioning in the rat Circ. Res. 75 1994 586 590
27. P. Ping, J. Zhang, Y. Qiu, X.L. Tang, S. Manchikalapudi, and X. Cao Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity Circ. Res. 81 1997 404 414
28. G.S. Liu, M.V. Cohen, D. Mochly-Rosen, and J.M. Downey Protein kinase C-epsilon responsible for the protection of preconditioning in rabbit cardiomyocytes J. Mol. Cell. Cardiol. 31 1999 1937 1948
29. P. Ping, C. Song, J. Zhang, Y. Guo, X. Cao, and R.C. Li Formation of protein kinase C(epsilon)-Lck signaling modules confers cardioprotection J. Clin. Invest. 109 2002 499 507
30. M.O. Gray, J.S. Karliner, and D. Mochly-Rosen A selective epsilon-protein kinase C antagonist inhibit protection of cardiac myocytes from hypoxia-induced cell death J. Biol. Chem. 272 1997 30945 30950
31. P. Ping, H. Takano, J. Zhang, X.L. Tang, Y. Qiu, and R.C. Li Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning Circ. Res. 84 1999 587 604
32. C.P. Baines, M. Goto, and J.M. Downey Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium J. Mol. Cell. Cardiol. 29 1997 207 216
33. T. Sato, B. O'Rourke, and E. Marban Modulation of mitochondrial ATP-dependent K+ channels by protein kinase C Circ. Res. 83 1998 110 114
34. R.D. Edmondson, T.M. Vondriska, K.J. Biederman, J. Zhang, R.C. Jones, and Y. Zheng Protein kinase C epsilon signaling complexes include metabolism- and transcription/translation-related proteins: complimentary separation techniques with LC/MS/MS Mol. Cell. Proteomics 1 2002 421 433
35. R. Bajgar, S. Seetharaman, A.J. Kowaltowski, K.D. Garlid, and P. Paucek Identification and properties of a novel intracellular (mitochondrial) ATP-sensitive potassium channel in brain J. Biol. Chem. 276 2001 33369 33374
36. D.X. Zhang, Y.F. Chen, W.B. Campbell, A.P. Zou, G.J. Gross, and P.L. Li Characteristics and superoxide-induced activation of reconstituted myocardial mitochondrial ATP-sensitive potassium channels Circ. Res. 89 2001 1177 1183
37. K.D. Garlid, P. Paucek, V. Yarov-Yarovoy, H.N. Murray, R.B. Darbenzio, and A.J. D'Alonzo Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection Circ. Res. 81 1997 1072 1082
38. Y. Liu, T. Sato, B. O'Rourke, and E. Marban Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation 97 1998 2463 2469
39. B. O'Rourke Evidence for mitochondrial K+ channels and their role in cardioprotection Circ. Res. 94 2004 420 432
40. N. Sasaki, T. Sato, A. Ohler, B. O'Rourke, and E. Marban Activation of mitochondrial ATP-dependent potassium channels by nitric oxide Circulation 101 2000 439 445
41. K.D. Garlid, P. Paucek, V. Yarov-Yarovoy, X. Sun, and P.A. Schindler The mitochondrial KATP channel as a receptor for potassium channel openers J. Biol. Chem. 271 1996 8796 8799
42. H. Tong, K. Imahashi, C. Steenbergen, and E. Murphy Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective Circ. Res. 90 2002 377 379
43. M.S. Marber, D.S. Latchman, J.M. Walker, and D.M. Yellon Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction Circulation 88 1993 1264 1272
44. N. Yamashita, S. Hoshida, K. Otsu, M. Asahi, T. Kuzuya, and M. Hori Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation J. Exp. Med. 189 1999 1699 1706
45. H. Takano, X.L. Tang, Y. Qiu, Y. Guo, B.A. French, and R. Bolli Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism Circ. Res. 83 1998 73 84
46. N. Yamashita, S. Hoshida, K. Otsu, N. Taniguchi, T. Kuzuya, and M. Hori The involvement of cytokines in the second window of ischaemic preconditioning Br. J. Pharmacol. 13 2000 415 422
47. H. Takano, S. Manchikalapudi, X.L. Tang, Y. Qiu, A. Rizvi, and A.K. Jadoon Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits Circulation 98 1998 441 449
48. D. Alcindor, J.G. Krolikowski, P.S. Pagel, D.C. Warltier, and J.R. Kersten Cyclooxygenase-2 mediates ischemic, anesthetic, and pharmacologic preconditioning in vivo Anesthesiology 100 2004 547 554
49. K. Shinmura, X.L. Tang, Y. Wang, Y.T. Xuan, S.Q. Liu, and H. Takano Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits Proc. Natl. Acad. Sci. U. S. A. 97 2000 10197 10202
50. Z.Q. Zhao, J.S. Corvera, M.E. Halkos, F. Kerendi, N.P. Wang, and R.A. Guyton Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning Am. J. Physiol., Heart Circ. Physiol. 285 2003 H579 H588
51. A. Tsang, D.J. Hausenloy, M.M. Mocanu, and D.M. Yellon Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway Circ. Res. 95 2004 230 232
52. E.G. Lakatta Cardiovascular regulatory mechanisms in advanced age Physiol. Rev. 73 1993 413 467
53. E.G. Lakatta, and S.J. Sollott The "heartbreak" of older age Mol. Interv. 2 2002 431 446
54. E.G. Lakatta, and D. Levy Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II. The aging heart in health: links to heart disease Circulation 107 2003 346 354
55. G. Olivetti, E. Cigola, R. Maestri, D. Corradi, C. Lagrasta, and S.R. Gambert Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the proportion of mononucleated and multinucleated myocytes in the human heart J. Mol. Cell. Cardiol. 28 1996 1463 1477
56. P. Anversa, and J. Kajstura Ventricular myocytes are not terminally differentiated in the adult mammalian heart Circ. Res. 83 1998 1 14
57. B. Nadal-Ginard, J. Kajstura, A. Leri, and P. Anversa Myocyte death, growth, and regeneration in cardiac hypertrophy and failure Circ. Res. 92 2003 139 150
58. J. Kajstura, B. Pertoldi, A. Leri, C.A. Beltrami, A. Deptala, and Z. Darzynkiewicz Telomere shortening is an in vivo marker of myocyte replication and aging Am. J. Pathol. 156 2000 813 819
59. M.H. Soonpaa, and L.J. Field Survey of studies examining mammalian cardiomyocyte DNA synthesis Circ. Res. 83 1998 15 26
60. A.P. Beltrami, L. Barlucchi, D. Torella, M. Baker, F. Limana, and S. Chimenti Adult cardiac stem cells are multipotent and support myocardial regeneration Cell 114 2003 763 776
61. L.J. Field Modulation of the cardiomyocyte cell cycle in genetically altered animals Ann. N.Y. Acad. Sci. 1015 2004 160 170
62. C. Chimenti, J. Kajstura, D. Torella, K. Urbanek, H. Heleniak, and C. Colussi Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure Circ. Res. 93 2003 604 613
63. D. Torella, M. Rota, D. Nurzynska, E. Musso, A. Monsen, and I. Shiraishi Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression Circ. Res. 94 2004 514 524
64. E.G. Lakatta Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III. Cellular and molecular clues to heart and arterial aging Circulation 107 2003 490 497
65. J.L. Fleg, S. Schulman, F. O'Connor, L.C. Becker, G. Gerstenblith, and J.F. Clulow Effects of acute beta-adrenergic receptor blockade on age-associated changes cardiovascular performance during dynamic exercise Circulation 90 1994 2333 2341
66. R.P. Xiao, E.D. Tomhave, D.J. Wang, X. Ji, M.O. Boluyt, and H. Cheng Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases J. Clin. Invest. 101 1998 1273 1282
67. J.D. Kilts, T. Akazawa, M.D. Richardson, and M.M. Kwatra Age increases cardiac G alpha(i2) expression, resulting in enhanced coupling to G protein-coupled receptors J. Biol. Chem. 277 2002 31257 31262
68. S. Pepe, R.P. Xiao, C. Hohl, R. Altschuld, and E.G. Lakatta 'Cross talk' between opioid peptide and adrenergic receptor signaling in isolated rat heart Circulation 95 1997 2122 2129
69. O.E. Brodde, U. Konschak, K. Becker, F. Ruter, U. Poller, and J. Jakubetz Cardiac muscarinic receptors decrease with age. In vitro and in vivo studies J. Clin. Invest. 101 1998 471 478
70. G.E. Taffet, and C.A. Tate CaATPase content is lower in cardiac sarcoplasmic reticulum isolated from old rats Am. J. Physiol. 275 1998 H2087 H2094
71. M.T. Jiang, M.P. Moffat, and N. Narayanan Age-related alterations in the phosphorylation of sarcoplasmic reticulum and myofibrillar proteins and diminished contractile response to isoproterenol in intact rat ventricle Circ. Res. 72 1993 102 111
72. M.U. Koban, A.F. Moorman, J. Holtz, M.H. Yacoub, and K.R. Boheler Expressional analysis of the cardiac Na-Ca exchanger in rat development and senescence Cardiovasc. Res. 37 1998 405 423
73. I.R. Josephson, A. Guia, M.D. Stern, and E.G. Lakatta Alterations in properties of L-type Ca channels in aging rat heart J. Mol. Cell. Cardiol. 34 2002 297 308
74. A.M. Janczewski, H.A. Spurgeon, and E.G. Lakatta Action potential prolongation in cardiac myocytes of old rats is an adaptation to sustain youthful intracellular Ca2+ regulation J. Mol. Cell. Cardiol. 34 2002 641 648
75. R.G. Hansford, and D. Zorov Role of mitochondrial calcium transport in the control of substrate oxidation Mol. Cell. Biochem. 184 1998 359 369
76. O. Hano, K.Y. Bogdanov, M. Sakai, R.G. Danziger, H.A. Spurgeon, and E.G. Lakatta Reduced threshold for myocardial cell calcium intolerance in the rat heart with aging Am. J. Physiol. 269 1995 H1607 H1612
77. S. Pepe, N. Tsuchiya, E.G. Lakatta, and R.G. Hansford PUFA and aging modulate cardiac mitochondrial membrane lipid composition and Ca2+ activation of PDH Am. J. Physiol. 276 1999 H149 H158
78. S.W. Taylor, E. Fahy, B. Zhang, G.M. Glenn, D.E. Warnock, and S. Wiley Characterization of the human heart mitochondrial proteome Nat. Biotechnol. 21 2003 281 286
79. G. Beutner, V.K. Sharma, D.R. Giovannucci, D.I. Yule, and S.S. Sheu Identification of ryanodine receptor in rat heart mitochondria J. Biol. Chem. 276 2001 21482 21488
80. G. Csordas, and G. Hajnoczky Plasticity of mitochondrial calcium signaling J. Biol. Chem. 278 2003 42273 42282
81. E.G. Lakatta, S.J. Sollott, and S. Pepe The old heart: operating on the edge Novartis Found. Symp. 235 2001 172 196
82. F.H. Wilson, A. Hariri, A. Farhi, H. Zhao, K.F. Petersen, and H.R. Toka A cluster of metabolic defects caused by mutation in a mitochondrial tRNA Science 306 2004 1190 1194
83. A. Trifunovic, A. Wredenberg, M. Falkenberg, J.N. Spelbrink, A.T. Rovio, and C.E. Bruder Premature ageing in mice expressing defective mitochondrial DNA polymerase Nature 429 2004 417 423
84. S.W. Fannin, E.J. Lesnefsky, T.J. Slabe, M.O. Hassan, and C.L. Hoppel Aging selectively decreases oxidative capacity in rat heart interfibrillar mitochondria Arch. Biochem. Biophys. 372 1999 399 407
85. F.L. Rosenfeldt, S. Pepe, A. Linnane, P. Nagley, M. Rowland, and R. Ou The effects of ageing on the response to cardiac surgery: protective strategies for the ageing myocardium Biogerontology 3 2002 37 40
86. S. Pepe Mitochondrial function in ischaemia and reperfusion of the ageing heart Clin. Exp. Pharmacol. Physiol. 27 2000 745 750
87. S. Moghaddas, C.L. Hoppel, and E.J. Lesnefsky Aging defect at the QO site of complex III augments oxyradical production in rat heart interfibrillar mitochondria Arch. Biochem. Biophys. 414 2003 59 66
88. H. Esterbauer, R.J. Schaur, and H. Zollner Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Radic. Biol. Med. 11 1991 81 128
89. D.B. Zorov, C.R. Filburn, L.-O. Klotz, J.L. Zweier, and S.J. Sollott 'ROS-induced-ROS-release': a new phenomenon accompanying induction of the mitochrondrial permeability transition in cardiac myocytes J. Exp. Med. 192 2000 1001 1014
90. S. Pepe, N. Tsuchiya, E.G. Lakatta, and R.G. Hansford PUFA and aging modulate cardiac mitochondrial membrane lipid composition and Ca2+ activation of PDH Am. J. Physiol. 276 1999 H149 H158
91. J.H. Suh, E.T. Shigeno, J.D. Morrow, B. Cox, A.E. Rocha, and B. Frei Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-(alpha)-lipoic acid FASEB J. 15 2001 700 706
92. R.A. Fenton, E.W. Dickson, T.E. Meyer, and J.G. Dobson Jr. Aging reduces the cardioprotective effect of ischemic preconditioning in the rat heart J. Mol. Cell. Cardiol. 32 2000 1371 1375
93. R.A. Fenton, E.W. Dickson, T.E. Meyer, and J.G. Dobson Jr. Aging reduces the cardioprotective effect of ischemic preconditioning in the rat heart J. Mol. Cell Cardiol. 32 2003 1371 1375
94. R. Sniecinski, and H. Liu Reduced efficacy of volatile anesthetic preconditioning with advanced age in isolated rat myocardium Anesthesiology 100 2004 589 597
95. P. Abete, N. Ferrara, A. Cioppa, P. Ferrara, S. Bianco, and C. Calabrese Preconditioning does not prevent postischemic dysfunction in aging heart J. Am. Coll. Cardiol. 27 1996 1777 1786
96. P. Abete, G. Testa, N. Ferrara, D. De Santis, P. Capaccio, and L. Viati Cardioprotective effect of ischemic preconditioning is preserved in food-restricted senescent rats Am. J. Physiol., Heart Circ. Physiol. 282 2002 H1978 H1987
97. M. Tani, Y. Suganuma, H. Hasegawa, K. Shinmura, Y. Ebihara, and Y. Hayashi Decrease in ischemic tolerance with aging in isolated perfused Fischer 344 rat hearts: relation to increases in intracellular Na+ after ischemia J. Mol. Cell. Cardiol. 29 1997 3081 3089
98. R. Lu, C.P. Hu, H.W. Deng, and Y.J. Li Calcitonin gene-related peptide-mediated ischemic preconditioning in the rat heart: influence of age Regul. Pept. 99 2001 183 189
99. P. Abete, C. Calabrese, N. Ferrara, A. Cioppa, P. Pisanelli, and F. Cacciatore Exercise training restores ischemic preconditioning in the aging heart J. Am. Coll. Cardiol. 36 2000 643 650
100. D. Schulman, D.S. Latchman, and D.M. Yellon Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury Am. J. Physiol., Heart Circ. Physiol. 281 2001 H1630 H1636
101. J.P. Headrick, L. Willems, K.J. Ashton, K. Holmgren, J. Peart, and G.P. Matherne Ischaemic tolerance in aged mouse myocardium: the role of adenosine and effects of A1 adenosine receptor overexpression J. Physiol. 549 2003 823 833
102. K. Przyklenk, G. Li, and P. Whittaker No loss in the in vivo efficacy of ischemic preconditioning in middle-aged and old rabbits J. Am. Coll. Cardiol. 38 2001 1741 1747
103. P.G. Burns, I.B. Krunkenkamp, C.A. Calderone, R.J. Kirvaitis, G.R. Gaudette, and S. Levitsky Is the preconditioning response conserved in senescent myocardium? Ann. Thorac. Surg. 61 1996 925 929
104. P. Abete, D. de Santis, M. Condorelli, C. Napoli, and F. Rengo A four-year-old rabbit cannot be considered the right model for investigating cardiac senescence J. Am. Coll. Cardiol. 39 2002 1701
105. J. Mariani, R. Ou, M. Bailey, M. Rowland, P. Nagley, and F. Rosenfeldt Tolerance to ischemia and hypoxia is reduced in aged human myocardium J. Thorac. Cardiovasc. Surg. 120 2000 660 667
106. M. Loubani, S. Ghosh, and M. Galinanes The aging human myocardium: tolerance to ischemia and responsiveness to ischemic preconditioning J. Thorac. Cardiovasc. Surg. 126 2003 143 147
107. B. Bartling, C. Hilgefort, I. Friedrich, R.E. Silber, and A. Simm Cardio-protective determinants are conserved in aged human myocardium after ischemic preconditioning FEBS Lett. 555 2003 539 544
108. P. Abete, N. Ferrara, F. Cacciatore, A. Madrid, S. Bianco, and C. Calabrese Angina-induced protection against myocardial infarction in adult and elderly patients: a loss of preconditioning mechanism in the aging heart? J. Am. Coll. Cardiol. 30 1997 947 954
109. M. Jimenez-Navarro, J.J. Gomez-Doblas, J. Alonso-Briales, J.M. Hernandez Garcia, G. Gomez, and A.G. Alcantara Does angina the week before protect against first myocardial infarction in elderly patients? Am. J. Cardiol. 87 2001 11 15
110. T.M. Lee, S.F. Su, T.F. Chou, Y.T. Lee, and C.H. Tsai Loss of preconditioning by attenuated activation of myocardial ATP-sensitive potassium channels in elderly patients undergoing coronary angioplasty Circulation 105 2002 334 340
111. P. Abete, N. Ferrara, F. Cacciatore, E. Sagnelli, M. Manzi, and V. Carnovale High level of physical activity preserves the cardioprotective effect of preinfarction angina in elderly patients J. Am. Coll. Cardiol. 38 2001 1357 1365
112. G. Longobardi, P. Abete, N. Ferrara, A. Papa, R. Rosiello, and G. Furgi "Warm-up" phenomenon in adult and elderly patients with coronary artery disease: further evidence of the loss of "ischemic preconditioning" in the aging heart J. Gerontol., Ser. A, Biol. Sci. Med. Sci. 55 2000 M124 M129
113. T.B. Lindhardt, N. Gadsboll, H. Kelbaek, K. Saunamaki, J.K. Madsen, and P. Clemmensen Pharmacological modulation of the ATP sensitive potassium channels during repeated coronary occlusions: no effect on myocardial ischaemia or function Heart 90 2004 425 430
114. M.E. Faircloth, S.R. Redwood, and M.S. Marber Ischaemic preconditioning and myocardial adaptation to serial intracoronary balloon inflation: cut from the same cloth? Heart 90 2004 358 360
115. R.A. Kloner, K. Przyklenk, T. Shook, and C.P. Cannon Protection conferred by preinfarct angina is manifest in the aged heart: evidence from the TIMI 4 Trial J. Thromb. Thrombolysis 6 1998 89 92
116. E.G. Lakatta, and F.C. Yin Myocardial aging: functional alterations and related cellular mechanisms Am. J. Physiol. 242 1982 H927 H941
117. Y. Nitta, K. Abe, M. Aoki, I. Ohno, and S. Isoyama Diminished heat shock protein 70 mRNA induction in aged rat hearts after ischemia Am. J. Physiol. 267 1994 H1795 H1803
118. R. Bolli Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research J. Mol. Cell. Cardiol. 33 2001 1897 1918
119. T.C. Chou, M.H. Yen, C.Y. Li, and Y.A. Ding Alterations of nitric oxide synthase expression with aging and hypertension in rats Hypertension 31 1998 643 648
120. D.H. Korzick, D.A. Holiman, M.O. Boluyt, M.H. Laughlin, and E.G. Lakatta Diminished alpha1-adrenergic-mediated contraction and translocation of PKC in senescent rat heart Am. J. Physiol., Heart Circ. Physiol. 281 2001 H581 H589
121. M. Tani, Y. Honma, H. Hasegawa, and K. Tamaki Direct activation of mitochondrial K(ATP) channels mimics preconditioning but protein kinase C activation is less effective in middle-aged rat hearts Cardiovasc. Res. 49 2001 56 68
122. G.A. Fitzgerald Coxibs and cardiovascular disease N. Engl. J. Med. 351 2004 1709 1711
123. R.L. Engler, and D.M. Yellon Sulfonylurea KATP blockade in type II diabetes and preconditioning in cardiovascular disease. Time for reconsideration Circulation 94 1996 2297 2301
124. K.N. Garratt, P.A. Brady, N.L. Hassinger, D.E. Grill, A. Terzic, and D.R. Holmes Jr. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction J. Am. Coll. Cardiol. 33 1999 119 124
125. J.J. Meier, B. Gallwitz, W.E. Schmidt, A. Mugge, and M.A. Nauck Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important? Heart 90 2004 9 12
126. W.C. Stanley Partial fatty acid oxidation inhibitors for stable angina Expert Opin. Investig. Drugs 11 2002 615 629
127. J. Minners, E.J. van den Bos, D.M. Yellon, H. Schwalb, L.H. Opie, and M.N. Sack Dinitrophenol, cyclosporin A, and trimetazidine modulate preconditioning in the isolated rat heart: support for a mitochondrial role in cardioprotection Cardiovasc. Res. 47 2000 68 73
128. R. Bolli, L. Becker, G. Gross, R. Mentzer Jr., D. Balshaw, D.A. Lathrop NHLBI working group on the translation of therapies for protecting the heart from ischemia Myocardial protection at a crossroads: the need for translation into clinical therapy Circ. Res. 95 2004 125 134